For New York City in particular, there is a long tradition of ethnographic studies of the subject (e.g., Johnson et al., 1985; Preble and Casey, 1969) that has produced rich descriptions of individual markets. For example, Bourgois spent 3 years in a Hispanic section of Harlem observing the activities and lives of a small group of dealers (Bourgois, 1996). A report of the National Research Council (2001) made extensive reference to work by Curtis and Wendel (2000).
This platform contains insights related to the latest global, regional and subregional estimates and trends in drug demand and drug supply in the form of global, regional and sub-regional Key Findings that are easy to search. The user can explore the key findings sequentially following a narrative by their topic of choice. Alternatively, the user can search these key findings using the different filter options by region, topic, market, and more, or search by keyword using the search bar, by going to the “Advanced Search” section. Each key finding contains insights presented through succinct messages, supported by a number of data visualizations based on the latest available data, including interactive graphs, infographics and maps. The data and visualizations from each key finding can be downloaded by clicking on the corresponding link. The Online World Drug Report 2025 contains more than 100 key findings with over 300 data visualizations.
This perspective may give short shrift to the very large social costs of drug abuse and dependence that do not result in death, particularly those costs generated by the markets for methamphetamine and cocaine. Fentanyl has saturated many U.S. drug markets as a cheaper and more potent replacement for heroin, and entered others where heroin was rare or absent. Fentanyl now also shows up primarily in fatal overdoses that also involve cocaine and methamphetamine; it is not just a substitute opioid. Cocaine use in the United States has declined substantially perhaps as a result of the falling price of methamphetamine. The significant decline in cocaine use is demand-driven since cocaine production has expanded substantially in the Andes over the last decade. Methamphetamine now is cheaper and more potent than the product that existed in the previous wave of the early 1990s.
- Enhanced manufacturing technologies and global access expansion contribute to the segment’s rapid market penetration.
- The growing market adoption of innovative and modern medicines is another key driver of the pharmaceutical market.
- The implicit features of many legal markets in modern economies—for example, quality certification and available legal mechanisms to guard against fraud—are typically absent from illegal drug markets.
- CVS, which administered 9 million shots in 2019, is anticipated to reach 18 million in 2020.
Yet the same might be said of the cross-country traveler who stops at a roadside diner or the life insurance company that is forbidden by law from performing certain informative medical tests. Prior to the founding of eBay and related websites, search costs and quality differences were dominant factors in the markets for collectibles and antiques. Intervention was launched about the same time as a nonprice influence shifted the demand curve out (up and to the right).
The pharmaceutical industry is growing strongly due to the growing geriatric population, which requires continuous healthcare due to age-related health issues. Based on type, the conventional drugs (small molecules) segment accounted for the largest revenue share of 54.74% in 2024, due to their well-established manufacturing process, predictable pharmacokinetics, and oral bioavailability. Additionally, their extensive and proven history of successful clinical use, diverse therapeutic applications, and patent expirations enabling generic competition contribute to their widespread adoption. The global pharmaceuticals market is expected to grow at a compound annual growth rate of 6.12% from 2025 to 2030 to reach USD 2,350.43 billion by 2030.
US Pharmaceutical Market Outlook And Strategic Insights By 2030
The generic drugs market refers to the market for pharmaceutical products that are bioequivalent to brand-name drugs but are sold under their generic names. These drugs have the same active ingredients, dosage form, strength, route of administration, and intended use as their brand-name counterparts. The generic drugs market plays a critical role in providing affordable and accessible medications to patients worldwide.
Global Market Dynamics: Size, Scope, And Trajectory
In addition, demand for personalized treatments, long-term care solutions, and preventive healthcare drives the segment. Government initiatives and technological advancements in diagnostics and therapeutics further support the market expansion among the geriatric population. Market participants are increasingly targeting growth in emerging regions such as Asia-Pacific, Latin America, and the Middle East. Factors driving expansion include rising disease burden, improving healthcare infrastructure, and favorable government policies.
Route Of Administration
The report then profiles the competitive arena, comparing the strategies of industry leaders and the critical role of patent intelligence. The subsequent section brings in the human element, exploring patient and physician perspectives that are crucial for market adoption. Finally, the report concludes with a forward-looking outlook, offering strategic recommendations for stakeholders to navigate the evolving market through 2035. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal.
The UK Drugs Market Trends
The negative impacts of illicit drug markets are multifaceted and far-reaching, which is why they remain a key threat to the security of the European Union and the safety of its citizens. This is primarily attributed to the fact that in the global scenario, there has been an increasing prevalence of several chronic disorders. This has led to increasing demand from patients due to their unmet clinical needs and demand for positive clinical outcomes. A number of these chronic disorders are often refractory in nature and require the administration of aggressive prescribed therapies.
- Thus, the industry players are focusing on introducing orphan drugs to treat life-threatening or seriously debilitating conditions among patients, such as cystic fibrosis, acromegaly/gigantism, and Duncan’s Syndrome, among others.
- One of the critical elements driving the global market growth is the increasing launches of the generic equivalents of several key drugs in strong markets such as the U.S.
- This collaboration aims to enhance sales, service, and customer relationship management, facilitating the opening of flagship outlets and numerous dealerships.
- They are directly injected into body fluids to enhance their therapeutic action, i.e., they have a faster onset of action.
- Spotlight on Maryland’s interaction with the man on Thursday marked the six-week anniversary of a mass drug overdose event that happened in the same Penn North open-air drug market.
What Is Covered Under Pharmaceutical API Manufacturing Market?
If consumers are targeted (e.g., through sell-and-bust operations), it enhances the bargaining power of sellers and hence may lead to higher prices or the equivalent in terms of reduced quality. Limited data—for example, on actual time served by drug dealers—raises questions about the cost-effectiveness of tough enforcement. Levitt and Venkatesh (2000) provide a uniquely detailed organizational analysis of one drug-selling operation. Drawing on internal financial data, the authors describe the franchise nature of Chicago drug selling, in which gangs and their subunits control specific areas where illegal transactions can occur. They suggest that this is in effect a tournament compensation system, in which low-level dealers earn relatively low wages in return for the prospect of advancement.
FUTURE TRENDS
Also, in North America, especially the US, they greatly emphasize on patient-oriented, convenient delivery system and expenditure on healthcare resources. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, Noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally. These factors are expected to increase the patient pool globally, thereby driving the pharmaceutical drug market during the forecast period.
Companies Mentioned
As defined above, the total price elasticity of demand is the sum of the conditional elasticity and the participation elasticity. Currently, the drug research offers more analyses on participation elasticities than on the other two quantities. Both this line of research and the economics literature would be enhanced by more collaborative work. Drug markets include many interconnected or unobservable components that complicate economic analysis. For example, enhanced law enforcement efforts may hinder consumer efforts to switch suppliers or compare prices.
Top Companies
Meanwhile, the man also said that “stop snitching” in Baltimore remains relevant, a phrase that gained fame in 2004 when Rodney Thomas released the Stop Snitchin DVD. The most important key figures provide you with a compact summary of the topic of “Pharmaceutical industry in China” and take you straight to the corresponding statistics. Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe.
An excellent and undercited study is that by Fuentes (1998) describing Colombian-run importing organizations in the early 1990s. Kilmer and Reuter (2009) provide a more fully documented price chain for both cocaine and heroin for 2006. However, several alleyways off the intersection were busy with dozens of people visibly using recreational drugs.
